(S1 (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NN NF-kappaB) (NN signaling))) (PP (IN in) (NP (NN cpdm) (NNS BMDC))) (. .))))
(S1 (S (S (NP (NP (NP (NP (NN WT)) (CC and) (NP (NN cpdm))) (NNS BMDC)) (PRN (-LRB- -LRB-) (NP (NP (NN 2x106) (NNS cells)) (PP (IN in) (NP (ADJP (NP (CD 0.5) (NN mL)) (JJ complete)) (NN medium)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN stimulated) (PP (IN with) (NP (NP (NP (ADJP (CD 100) (NN ng/mL)) (NN LPS)) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (CC or) (NP (NP (ADJP (CD 25) (NN microg/mL)) (NN poly) (NN I:C)) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (PP (IN At) (NP (QP (CD 0) (, ,) (CD 15) (, ,) (CD 30) (, ,) (CC and) (CD 60)) (NNS minutes))) (, ,) (NP (JJ whole-cell) (NNS lysates)) (VP (VBD were) (VP (VBN obtained) (PP (CC and) (JJ subject) (TO to) (NP (NP (NNS immunoblots)) (PP (IN with) (NP (NP (NNS antibodies)) (PP (IN against) (NP (NP (NNS proteins)) (VP (VBN involved) (PP (IN in) (NP (NP (NP (NN NF-kappaB)) (, ,) (NP (NN TBK1/IRF3)) (, ,) (NP (NN ERK1/2)) (, ,) (CC and) (NP (NN p38))) (NN signaling) (NNS pathways))))))))))))) (. .)))
(S1 (S (S (NP (NN Beta-actin)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NN loading) (NN control)))))) (. .)))
(S1 (S (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (NP (JJ Cellular) (NNS levels)) (PP (IN of) (NP (NP (NN p-IKK1/2)) (CC and) (NP (NN p-IkappaBalpha)))) (PP (IN in) (NP (NP (NN LPS-)) (CC or) (NP (NN poly) (JJ I:C-stimulated) (NN BMDC))))) (VP (VBD were) (VP (VP (VBN quantitated) (PP (IN with) (NP (NP (NN ImageJ)) (PRN (-LRB- -LRB-) (NP (NN NIH)) (-RRB- -RRB-))))) (CC and) (VP (VBN presented) (PP (IN as) (NP (NN trend) (NNS lines))))))) (. .)))
(S1 (S (S (NP (NNS Results)) (VP (VBP are) (ADJP (JJ representative) (PP (IN of) (NP (QP (IN at) (JJS least) (CD two)) (JJ independent) (NNS experiments)))))) (. .)))
